More than half a dozen U.S. Catholic bishops, including Denver Archbishop James Golka, met with President Donald Trump in the Oval Office on October 22. The gathering concluded with the faith leaders standing around the iconic Resolute desk to pray for the president and the nation.
Organized by the White House Faith Office as part of an ongoing initiative to engage with religious leaders, the meeting focused heavily on shared policy interests. According to White House Faith Director Jenny Korn, the discussions covered topics such as religious freedom, school choice, religious visas, and life policies. Korn emphasized that the meeting was centered on “policy in action,” rather than politics.
Before the meeting ended, Archbishop Golka led the group in an intercessory prayer, thanking God for the government and the presidency, and invoking the Holy Spirit to “surround our country” and protect it from evil. Following the event,Golka released a statement expressing hope that the meeting would “foster further dialogue on the sanctity of life, human dignity and other issues of concern to the Catholic Church.”
Other prominent clergy in attendance included Archbishop Emeritus Joseph Naumann of Kansas City, Bishop Edward Burns of Dallas, and Bishop Michael Barber of Oakland. Paula White-Cain, Trump’s longtime spiritual adviser, also attended the meeting.
The U.S. Conference of Catholic Bishops (USCCB) was quick to clarify its lack of involvement in the Oval Office visit.USCCB spokesperson Chieko Noguchi explicitly stated that the event was not organized by, nor affiliated with, the Conference.
The meeting highlights the complex, multi-layered relationship between American Catholic leadership and the administration. While the USCCB has frequently aligned with Trump on religious liberty, gender ideology, and certain pro-life initiatives, the bishops have also openly disagreed with the administration on several major fronts. These sharp disagreements include the administration’s ongoing mass-deportation efforts, federal support for IVF, and the current administration’s failure to reverse policies regarding mail-order abortion medications.










